{ "company_number": "08371318", "name": "HDT Pharma Consulting Limited", "url": "/company/08371318", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2013-01-23", "dissolved_on": null, "sic_codes": [ { "code": "70229", "description": "Management consultancy activities other than financial management", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/70229" } ], "registered_address": { "id": 1949971, "url": "/address/1949971", "line1": "123 HALLGATE", "line2": "", "post_town": "COTTINGHAM", "county": "EAST RIDING OF YORKSHIRE", "country": "ENGLAND", "postcode": "HU16 4DA" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08371318", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-10-31", "last_made_up": "2025-01-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08371318/accounts/2025-01-31", "pdf_url": "/company/08371318/accounts/2025-01-31.pdf", "made_up_date": "2025-01-31", "period_start": "2025-01-31", "period_end": "2025-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1433.00", "debtors": "1272.00", "cash_bank_in_hand": "56066.00", "current_assets": "57338.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "56114.00", "total_assets_less_current_liabilities": "57547.00", "net_assets_liabilities": "57277.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2025.zip" }, { "url": "/company/08371318/accounts/2024-01-31", "pdf_url": "/company/08371318/accounts/2024-01-31.pdf", "made_up_date": "2024-01-31", "period_start": "2024-01-31", "period_end": "2024-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "2479.00", "debtors": "873.00", "cash_bank_in_hand": "87516.00", "current_assets": "88389.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "86721.00", "total_assets_less_current_liabilities": "89200.00", "net_assets_liabilities": "88731.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2024.zip" }, { "url": "/company/08371318/accounts/2023-01-31", "pdf_url": "/company/08371318/accounts/2023-01-31.pdf", "made_up_date": "2023-01-31", "period_start": "2023-01-31", "period_end": "2023-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1350.00", "debtors": "1130.00", "cash_bank_in_hand": "143314.00", "current_assets": "144444.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "138998.00", "total_assets_less_current_liabilities": "140348.00", "net_assets_liabilities": "140093.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2023.zip" }, { "url": "/company/08371318/accounts/2022-01-31", "pdf_url": "/company/08371318/accounts/2022-01-31.pdf", "made_up_date": "2022-01-31", "period_start": "2022-01-31", "period_end": "2022-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "2418.00", "debtors": "10554.00", "cash_bank_in_hand": "173666.00", "current_assets": "186994.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "151449.00", "total_assets_less_current_liabilities": "153867.00", "net_assets_liabilities": "153409.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2022.zip" }, { "url": "/company/08371318/accounts/2021-01-31", "pdf_url": "/company/08371318/accounts/2021-01-31.pdf", "made_up_date": "2021-01-31", "period_start": "2021-01-31", "period_end": "2021-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "3411.00", "debtors": "1174.00", "cash_bank_in_hand": "71949.00", "current_assets": "73123.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "64800.00", "total_assets_less_current_liabilities": "68211.00", "net_assets_liabilities": "67564.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2021.zip" }, { "url": "/company/08371318/accounts/2020-01-31", "pdf_url": "/company/08371318/accounts/2020-01-31.pdf", "made_up_date": "2020-01-31", "period_start": "2020-01-31", "period_end": "2020-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1937.00", "debtors": "7180.00", "cash_bank_in_hand": "82766.00", "current_assets": "89946.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "79005.00", "total_assets_less_current_liabilities": "80942.00", "net_assets_liabilities": "80575.00", "called_up_share_capital": "200.00", "profit_loss_account_reserve": "80375.00", "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2020.zip" }, { "url": "/company/08371318/accounts/2019-01-31", "pdf_url": "/company/08371318/accounts/2019-01-31.pdf", "made_up_date": "2019-01-31", "period_start": "2019-01-31", "period_end": "2019-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1993.00", "debtors": null, "cash_bank_in_hand": "97978.00", "current_assets": "97978.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "96993.00", "total_assets_less_current_liabilities": "98986.00", "net_assets_liabilities": "98608.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2019.zip" }, { "url": "/company/08371318/accounts/2018-01-31", "pdf_url": "/company/08371318/accounts/2018-01-31.pdf", "made_up_date": "2018-01-31", "period_start": "2018-01-31", "period_end": "2018-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "2656.00", "debtors": null, "cash_bank_in_hand": "165472.00", "current_assets": "165976.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "141946.00", "total_assets_less_current_liabilities": "144602.00", "net_assets_liabilities": "144098.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2018.zip" }, { "url": "/company/08371318/accounts/2017-01-31", "pdf_url": "/company/08371318/accounts/2017-01-31.pdf", "made_up_date": "2017-01-31", "period_start": "2017-01-31", "period_end": "2017-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "1755.00", "debtors": "13500.00", "cash_bank_in_hand": "136398.00", "current_assets": "151211.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "115317.00", "total_assets_less_current_liabilities": "117072.00", "net_assets_liabilities": "116739.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2017.zip" }, { "url": "/company/08371318/accounts/2016-01-31", "pdf_url": "/company/08371318/accounts/2016-01-31.pdf", "made_up_date": "2016-01-31", "period_start": "2016-01-31", "period_end": "2016-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1930.00", "debtors": null, "cash_bank_in_hand": "148425.00", "current_assets": "161513.00", "creditors_due_within_one_year": "34401.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "127112.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "129042.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "128942.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2016.zip" }, { "url": "/company/08371318/accounts/2015-01-31", "pdf_url": "/company/08371318/accounts/2015-01-31.pdf", "made_up_date": "2015-01-31", "period_start": "2015-01-31", "period_end": "2015-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1954.00", "debtors": null, "cash_bank_in_hand": "90631.00", "current_assets": "103617.00", "creditors_due_within_one_year": "33543.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "70074.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "72028.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "71928.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2015.zip" }, { "url": "/company/08371318/accounts/2014-01-31", "pdf_url": "/company/08371318/accounts/2014-01-31.pdf", "made_up_date": "2014-01-31", "period_start": "2014-01-31", "period_end": "2014-01-31", "entity_name": "HDT Pharma Consulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "277.00", "debtors": null, "cash_bank_in_hand": "49333.00", "current_assets": "59233.00", "creditors_due_within_one_year": "24765.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "34468.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "34745.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "34645.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08371318/filing-history" }, "confirmation_statement": { "next_due": "2026-07-17", "last_made_up": "2025-07-03" }, "officers": [ { "name": "AL-AZAWI, Hibah", "person_url": "/person/7154834", "role": "director", "appointed_on": "2014-01-06", "resigned_on": "2017-02-10", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-08-13T10:02:05+00:00" }, { "name": "AL-AZAWI, Tahajud", "person_url": "/person/7154813", "role": "director", "appointed_on": "2017-07-01", "resigned_on": "2018-01-31", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-08-13T10:02:05+00:00" }, { "name": "AL-AZAWI, Tahajud", "person_url": "/person/7154813", "role": "director", "appointed_on": "2019-04-01", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-08-13T10:02:05+00:00" }, { "name": "AL-AZAWI, Dimah", "person_url": "/person/7154815", "role": "director", "appointed_on": "2013-01-23", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-08-13T10:02:05+00:00" } ], "psc": [ { "name": "Hibah Al-Azawi", "kind": "individual-person-with-significant-control", "person_url": "/person/1912027", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2016-04-06", "ceased_on": "2017-02-10", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Ms Tahajud Al-Azawi", "kind": "individual-person-with-significant-control", "person_url": "/person/4922942", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2017-07-01", "ceased_on": "2018-01-31", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Ms Tahajud Al-Azawi", "kind": "individual-person-with-significant-control", "person_url": "/person/4922942", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2019-07-04", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Ms Dimah Al-Azawi", "kind": "individual-person-with-significant-control", "person_url": "/person/1318099", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:50:00.959197+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }